Thyroid Cancer · Treatment

What are the treatment options for thyroid cancer?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Thyroid Cancer Answer length: short, citable
Quick answer

Treatment is stage- and site-specific, and usually combines active surveillance with serial ultrasound for selected low-risk papillary microcarcinomas, thyroid lobectomy for small, unifocal, intrathyroidal tumours without nodal disease and total thyroidectomy when indicated by size, multifocality, extrathyroidal extension, nodal disease or patient preference. Early-stage disease is generally treated with one modality (surgery or radiotherapy), while locally advanced disease needs combined modality treatment planned by a multidisciplinary team.

In detail

The decision is made by a tumour board including head and neck surgery, radiation oncology, medical oncology, radiology, pathology, dentistry, nutrition and speech/swallow rehabilitation. Functional outcome — speech, swallowing, breathing and appearance — is considered alongside cancer control.

Ask your team explicitly whether the goal is curative, organ-preserving or palliative, and whether a clinical trial is available. NCCN and NCI patient guidelines are a useful checklist for these questions.

  • Active surveillance with serial ultrasound for selected low-risk papillary microcarcinomas
  • Thyroid lobectomy for small, unifocal, intrathyroidal tumours without nodal disease
  • Total thyroidectomy when indicated by size, multifocality, extrathyroidal extension, nodal disease or patient preference
  • Therapeutic neck dissection for clinically involved nodes; radioactive iodine (I-131) for selected intermediate/high-risk differentiated cancers
  • TSH suppression with levothyroxine tailored to risk; lifelong hormone replacement after total thyroidectomy
  • Targeted therapy (e.g. multikinase inhibitors, BRAF/MEK or RET inhibitors) for progressive radioactive-iodine-refractory disease; urgent multimodality therapy for anaplastic carcinoma

What this means in practice: this answer is part of the “Treatment” section of the Thyroid Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about thyroid cancer

See all 14 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Head and Neck Cancers (patient information) US National Cancer Institute · 2025
  3. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  4. Thyroid cancer in Asia: incidence, mortality in 2022, and future projections to 2050 European Journal of Cancer Prevention · 2026 · South Korea had the highest ASR in Asia: 7.6/100,000 in men and 39.5/100,000 in women.
  5. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  6. Thyroid Cancer (patient information) US National Cancer Institute · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.